Raymond E. Cabillot Sells 5,381 Shares of Pro-Dex, Inc. (NASDAQ:PDEX) Stock

Pro-Dex, Inc. (NASDAQ:PDEX) Director Raymond E. Cabillot sold 5,381 shares of the stock in a transaction on Tuesday, January 28th. The stock was sold at an average price of $41.64, for a total value of $224,064.84. Following the transaction, the director now owns 319,752 shares of the company’s stock, valued at $13,314,473.28. This represents a 1.66 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website.

Pro-Dex Price Performance

Shares of PDEX stock opened at $41.79 on Wednesday. Pro-Dex, Inc. has a 52 week low of $16.18 and a 52 week high of $59.60. The stock has a market capitalization of $136.24 million, a PE ratio of 27.14 and a beta of 0.56. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.94 and a current ratio of 3.41. The stock’s fifty day moving average is $47.75 and its 200-day moving average is $34.11.

Analyst Ratings Changes

A number of brokerages recently issued reports on PDEX. StockNews.com upgraded shares of Pro-Dex from a “buy” rating to a “strong-buy” rating in a research report on Saturday, December 14th. Ascendiant Capital Markets lifted their target price on shares of Pro-Dex from $30.00 to $52.00 and gave the company a “buy” rating in a research note on Monday, November 11th.

Institutional Investors Weigh In On Pro-Dex

A number of hedge funds have recently added to or reduced their stakes in the stock. Ritholtz Wealth Management acquired a new position in shares of Pro-Dex during the fourth quarter worth approximately $572,000. Renaissance Technologies LLC raised its position in Pro-Dex by 7.9% in the 2nd quarter. Renaissance Technologies LLC now owns 12,240 shares of the medical instruments supplier’s stock worth $240,000 after purchasing an additional 900 shares during the last quarter. FMR LLC lifted its holdings in Pro-Dex by 34.9% during the 3rd quarter. FMR LLC now owns 3,973 shares of the medical instruments supplier’s stock worth $119,000 after buying an additional 1,028 shares in the last quarter. Geode Capital Management LLC boosted its position in Pro-Dex by 9.1% in the 3rd quarter. Geode Capital Management LLC now owns 27,435 shares of the medical instruments supplier’s stock valued at $819,000 after buying an additional 2,296 shares during the last quarter. Finally, Dimensional Fund Advisors LP increased its stake in shares of Pro-Dex by 5.1% in the 2nd quarter. Dimensional Fund Advisors LP now owns 63,036 shares of the medical instruments supplier’s stock valued at $1,238,000 after buying an additional 3,067 shares during the period. Institutional investors own 15.28% of the company’s stock.

About Pro-Dex

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.